Trial Profile
A study of Arina-1 for the treatment of lung dysfunction following lung transplant
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Ascorbic acid/bicarbonate/glutathione (Primary)
- Indications Lung disorders
- Focus Adverse reactions
- 04 Aug 2017 New trial record
- 06 Jan 2017 According to a Renovion Inc. media release, the company plans to initiate this study in first quarter of 2017.